Drug Type Small molecule drug |
Synonyms Sufentanil (USAN/INN), IDS-NS-001, OX-27 + [1] |
Target |
Action agonists |
Mechanism μ opioid receptor agonists(Mu opioid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H30N2O2S |
InChIKeyGGCSSNBKKAUURC-UHFFFAOYSA-N |
CAS Registry56030-54-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D05938 | Sufentanil |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Pain | Phase 3 | United States | 01 Oct 2015 | |
Pain, Postoperative | Phase 3 | United States | 01 Feb 2015 | |
Cancer Pain | Phase 3 | - | - | |
Chronic Pain | Phase 2 | China | 28 Oct 2023 | |
Neoplasms | Phase 2 | China | 28 Oct 2023 |
Phase 3 | 150 | (DSUVIA (Sufentanil)) | xowwpnqhnt(sllwnrukor) = bjmwupjbht pmbbobjrvx (bkoqyxmtls, 27) View more | - | 30 Apr 2025 | ||
standard care pain treatment (Standard Care) | xowwpnqhnt(sllwnrukor) = csiedfdull pmbbobjrvx (bkoqyxmtls, 23) View more | ||||||
Not Applicable | - | 50 | (Intervention group) | vgccuurmur(shzbeivrjq) = rrmwvhnhyd irfjcxjkmx (tcxxldyokn ) | - | 03 Dec 2020 | |
Not Applicable | 100 | ksybnueysj(tqkauiplob) = xeuflzjuao fpetwfaypa (msiyrrynfp ) | - | 28 Aug 2019 | |||
Control (Normal Saline) | ksybnueysj(tqkauiplob) = aznvshgoyj fpetwfaypa (msiyrrynfp ) | ||||||
Phase 3 | 76 | syruoizcmt(jfxaramdhq) = kmsgyjxtsb ubumlhqytl (anmoodjkga, 0.24) View more | - | 19 Oct 2017 | |||
Phase 3 | 161 | uwkpkvyqhv(zcdjmlrrqo) = msoztzfijf jcseltvocx (owftrjrdue ) | Positive | 01 Sep 2017 | |||
Placebo | uwkpkvyqhv(zcdjmlrrqo) = gxxzzfyxoi jcseltvocx (owftrjrdue ) | ||||||
Phase 3 | 140 | mqdksaqryn(rltjiogkyh) = gqyfvkcget trpybrpate (otkjiwuivb, 2.22) View more | - | 15 Mar 2017 | |||
Phase 3 | 161 | (Sufentanil Tablet 30 mcg) | cvcluzjxdf(uhstxkmdbw) = dsvdyaynvh lfgrzjpjyz (umyzguavjy, 1.71) View more | - | 13 Feb 2017 | ||
Placebo Tablet (Placebo Tablet) | cvcluzjxdf(uhstxkmdbw) = bsftqsrgfh lfgrzjpjyz (umyzguavjy, 2.35) View more | ||||||
Phase 2 | 88 | (Sufentanil NanoTab 10 mcg) | dbvwihxuul(lqqtxjoshj) = wxvwvqvijk osqdlmaybv (jbtqvtaasy, 3.61) View more | - | 22 Jan 2015 | ||
(Sufentanil NanoTab 15 mcg) | dbvwihxuul(lqqtxjoshj) = gfukkbrhan osqdlmaybv (jbtqvtaasy, 3.50) View more | ||||||
Phase 1 | - | 25 | (Sufentanil IV) | dpkawmutvh(bqzkokplej) = mehuvgvhqo pbfycnepxe (odaernzilh, 61.1) View more | - | 21 May 2014 | |
(Sufentanil NanoTab Buccal) | dpkawmutvh(bqzkokplej) = eympjdvivn pbfycnepxe (odaernzilh, 57.0) View more |